Giuseppe Viale

Top papers

• American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

  M. Elizabeth H. Hammond, Daniel F. Hayes, Mitch Dowsett, et al.·2010·Journal of Clinical Oncology
  ↗ 4,242OA
• Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

  Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks, et al.·2013·Journal of Clinical Oncology
  ↗ 4,039OA
• Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

  Aron Goldhirsch, Eric P. Winer, Alan S. Coates, et al.·2013·Annals of Oncology
  ↗ 3,692OA
• The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

  Roberto Salgado, Carsten Denkert, Sandra Demaria, et al.·2014·Annals of Oncology
  ↗ 3,095OA
• Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

  Antonio C. Wolff, M. Elizabeth Hammond, Kimberly H. Allison, et al.·2018·Journal of Clinical Oncology
  ↗ 2,412OA
• A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer

  Umberto Veronesi, Giovanni Paganelli, Giuseppe Viale, et al.·2003·New England Journal of Medicine
  ↗ 2,204OA
• 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

  Fátima Cardoso, Laura J. van’t Veer, Jan Bogaerts, et al.·2016·New England Journal of Medicine
  ↗ 2,031OA
• Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes

  Umberto Veronesi, Giovanni Paganelli, Viviana Galimberti, et al.·1997·The Lancet
  ↗ 1,936OA
• Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

  Alan S. Coates, Eric P. Winer, Aron Goldhirsch, et al.·2015·Annals of Oncology
  ↗ 1,831OA
• Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

  Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks, et al.·2013·Archives of Pathology & Laboratory Medicine
  ↗ 1,788OA
• Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

  Sherene Loi, Nicolas Sirtaine, Fanny Piette, et al.·2013·Journal of Clinical Oncology
  ↗ 1,639
• Adjuvant Olaparib for Patients with <i>BRCA1</i> - or <i>BRCA2</i> -Mutated Breast Cancer

  Andrew Tutt, Judy E. Garber, Bella Kaufman, et al.·2021·New England Journal of Medicine
  ↗ 1,619OA